One Brooklyn Health names top leaders, and more | MED MOVES

After serving in an interim capacity for more than a year, Dr. Sandra Scott has been named the chief executive officer of One Brooklyn Health.

Dr. Sandra Scott and Arthur Gianelli

One Brooklyn Health also announced Arthur Gianelli as president and chief transformation officer. The system announced both appointments earlier this month.

Scott began serving as interim CEO in January 2024, and she secured the role on a permanent basis after a national search.

"I am honored and excited to serve as the new CEO of One Brooklyn Health - an institution that is so important to me and vital to the communities we serve,” Scott said.

Dr. Alexander Rovt, chairman of One Brooklyn Health’s board of trustees, praised Scott’s “robust experience and passionate commitment to One Brooklyn Health.”

"Now more than ever before, we need cornerstone, community hospitals to provide equitable access to healthcare for our families and patients that are in the most vulnerable neighborhoods,” Rovt said in a statement. “And Dr. Scott is the right leader for OBH."

Previously, Scott served as the executive director of the Brookdale Hospital Center for nearly three years and served as Chair of OBH's Department of Emergency Medicine.

Art Gianelli joins One Brooklyn Health from Mount Sinai Health Systems, where he served as president and chief transformation officer of the Mount Sinai Morningside Hospital.

“I'm looking forward to partnering with the Board, Dr. Scott and staff to build a health system that delivers efficient, effective, accessible and high-quality care to our patients,” Gianelli said in a statement.

Drew Early

Memorial Health appoints first chief operating officer

Drew Early has been named the inaugural chief operating officer of Memorial Health.

The system said the appointment of Early reflects the growth of the organization. Memorial Health operates five hospitals and a host of clinics in Illinois.

Early serves as CEO of Decatur Memorial Hospital, and he’ll continue to hold that role until a replacement is appointed.

Mandy Eaton, president and CEO of Memorial Health, said that Early will look to ensure more alignment throughout the system.

“Drew’s strong operational background, deep institutional knowledge, and commitment to our mission make him the ideal choice for this role,” Eaton said in a statement. “We’re confident his leadership will strengthen the system’s ability to deliver excellent care across the communities we serve.”

Early has been with Memorial Health since 2006, and he has been serving as CEO of Decatur Memorial Hospital since October 2019. He also served as vice president of operations at Springfield Memorial Hospital, among other roles in the system.

Ken Stevens

Medical City hospital gets new CEO

Ken Stevens has been named chief executive officer of Medical City Frisco in Frisco, Texas.

He began serving in the new role on May 14.

Before taking the post, Stevens served as the chief operating officer at Medical City Lewisville. He served as vice president of operations at Medical City Frisco from 2020 to 2023.

“Ken has a proven record of operational leadership across the Medical City Healthcare system of care, including his prior tenure at Medical City Frisco,” Ben Coogan, CEO of Medical City Plano, said in a statement. “As we continue to advance to meet healthcare demand in this growing community, I am confident Ken will lead Medical City Frisco to the next level of healthcare excellence.”

Stevens held a series of leadership roles at Medical City Plano for five years. He joined Medical City Healthcare in 2011, beginning as a financial analyst at Medical City Arlington.

Chetan Bettegowda, MD

Johns Hopkins Medical School names director of neurosurgery

Chetan Bettegowda, MD, has been named the new director of the department of neurosurgery for the Johns Hopkins University School of Medicine.

Bettegowda began serving in the role on May 15. He succeeds Henry Brem, MD, who had led the department since 2000.

Johns Hopkins hailed his research of central nervous system cancers.

Bettegowda also has served as the medical director of the Ludwig Center for Cancer Genetics and Therapeutics and director of the Reza Khatib Brain Tumor Research Center.

Kevin Sowers, president of Johns Hopkins Health System and executive vice president of Johns Hopkins Medicine, said Bettegowda’s appointment “reflects our commitment to fostering world-class leadership at the intersection of medicine and science.”

“With his remarkable experience and expertise, Dr. Bettegowda embodies the best of Johns Hopkins — a scientist, surgeon, mentor and leader dedicated to advancing medicine’s frontiers,” Sowers said in a statement.